A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma
Open Access
- 19 January 2006
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 20 (3) , 536-537
- https://doi.org/10.1038/sj.leu.2404104
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a caseHuman Pathology, 2005
- The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion geneOncogene, 2005
- PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocationLeukemia, 2005
- The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and DiagnosisMayo Clinic Proceedings, 2005
- The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2Cancer Research, 2005